Shopping Cart 0
Cart Subtotal
USD 0

Dry Eye Syndrome: Epidemiology Forecast to 2026

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 7990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 11985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Dry Eye Syndrome: Epidemiology Forecast to 2026

Summary

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye characterized by dryness, decreased tear production, or increased tear film evaporation. Patients with DES experience symptoms of discomfort, such as visual disturbance and tear film instability. Middle-aged and elderly people are most commonly affected because of the high prevalence of contact lens usage, systemic drug effects, autoimmune diseases, and refractive surgeries.

The epidemiology forecast for DES is supported by historical data obtained from peer-reviewed articles and population-based studies. The forecast methodology was kept consistent across the 8MM to allow for a meaningful comparison of the forecast prevalent cases of DES across these markets. These sources used questionnaires to assess DES symptoms, along with various diagnostic tests like aqueous tear flow, ocular surface damage, and measurements of tear film instability, for the 8MM in this analysis.

In the 8MM the total prevalent cases of DES are expected to increase from 267,680,785 cases in 2016 to 286,308,974 cases in 2026, at an Annual Growth Rate (AGR) of 0.70%. In 2026, China will have the highest number of total prevalent cases of DES in the 8MM with 205,637,090 total prevalent cases, whereas Spain will have the fewest number of total prevalent cases with 3,488,142 total prevalent cases in 2026. In the 8MM, the diagnosed prevalent cases are expected to increase from 100,585,137 cases in 2016 to 108,896,818 cases in 2026, at an AGR of 0.83%. In 2026, China will have the highest number of diagnosed prevalent cases of DES in the 8MM, with 64,251,395 diagnosed prevalent cases, whereas Spain will have the fewest number of diagnosed prevalent cases with 1,807,984 cases.

Scope

- The Dry Eye Syndrome (DES) Epidemiology Forecast Report provides an overview of the risk factors and global trends of DES in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China).

- This report also includes a 10-year epidemiology forecast for the diagnosed prevalent cases and total prevalent cases (both diagnosed and undiagnosed) of DES. The total prevalent cases and diagnosed prevalent cases of DES are segmented by sex, severity (mild, moderate, and severe), and age in 10-year increments (starting at ages 20-29 years and ending at ages 80 years and older).

- The Dry Eye Syndrome epidemiology forecast report is written and developed by Masters- and PhD-level epidemiologists.

- The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Dry Eye Syndrome (DES) Epidemiology Forecast report will allow you to-

- Develop business strategies by understanding the trends shaping and driving the global DES market.

- Quantify patient populations in the global DES market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DES therapeutics in each of the markets covered.

- Understand magnitude of DES population by severity.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Dry Eye Syndrome: Executive Summary 4

2.1 Related Reports 6

2.2 Upcoming Reports 6

3 Epidemiology 7

3.1 Disease Background 7

3.2 Risk Factors and Comorbidities 7

3.3 Global and Historical

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com